Showing results (81-90 of 326) with videos related to

Sort By:
Pageof 33
Nature|June 15, 2022
Signatures of copy number alterations in human cancerChristopher D Steele, Ammal Abbasi, S M Ashiqul Islam, et al.
Cancer Research Communications|June 28, 2023
Multiple Germline Events Contribute to Cancer Development in Patients with Li-Fraumeni SyndromeVallijah Subasri, Nicholas Light, Nisha Kanwar, et al.
Pediatric Blood & Cancer|December 20, 2011
Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindredCarol A Durno, Melyssa Aronson, Uri Tabori, et al.
Oncogene|August 24, 2005
Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acidMatthew F W Gee, Rika Tsuchida, Claudia Eichler-Jonsson, et al.
The Journal of Clinical Investigation|May 30, 2009
JNK1 determines the oncogenic or tumor-suppressive activity of the integrin-linked kinase in human rhabdomyosarcomaAdam D Durbin, Gino R Somers, Michael Forrester, et al.
Harefuah|September 1, 2005
[Infectious complications with herpes virus after ritual Jewish circumcision: a historical and cultural analysis]Benjamin Gesundheit, David Greenberg, Shlomo Walfish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2024
Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition SyndromesMary-Louise C Greer, Lisa J States, David Malkin, et al.
Genome Biology|October 10, 2014
OncoCis: annotation of cis-regulatory mutations in cancerDilmi Perera, Diego Chacon, Julie A I Thoms, et al.
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 16, 2008
Expression of insulin-like growth factor pathway proteins in rhabdomyosarcoma: IGF-2 expression is associated with translocation-negative tumorsShalini Makawita, Michael Ho, Adam D Durbin, et al.
Journal of Child Neurology|December 6, 2018
mTOR Inhibitors as a New Therapeutic Strategy in Treatment Resistant Epilepsy in Hemimegalencephaly: A Case ReportQi Xu, Shimrit Uliel-Sibony, Christopher Dunham, et al.
Pageof 33